Lee, Ji Hyun, Jimin Choi, Chang-Ki Min, Sung-Soo Park, Jae-Cheol Jo, Yoo Jin Lee, Jin Seok Kim, Hyeon-Seok Eom, Jongheon Jung, Joon Ho Moon, Hee Jeong Cho, Myung-won Lee, Sung-Soo Yoon, Ja Min Byun, Jae Hoon Lee, Je-Jung Lee, Sung-Hoon Jung, Ho-Jin Shin, Do Young Kim, Jun Ho Yi, Seung-Shin Lee, Young Rok Do, Dok Hyun Yoon, Hyungwoo Cho, Won Sik Lee, Ho Sup Lee, Jieun Uhm, Hyo Jung Kim, Hee Ryeong Jang, Sung-Hyun Kim, and Kihyun Kim. 2020. “Superior Outcomes and High-Risk Features With Carfilzomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed and Refractory Multiple Myeloma: Results of the Multicenter KMMWP2201 Study”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2024.285534.